Key Takeaways
- Clinical Bottom Line
- The Silicon Second Observer
Clinical Bottom Line
| Software Capability | Clinical Application Area | Operational Impact |
|---|---|---|
| CADe (Computer-Aided Detection) | Real-time highlighting of subtle polyps on the video monitor. | Significantly mitigates physician fatigue; boosts right-sided ADR by ~5%. |
| CADx (Computer-Aided Diagnosis) | Real-time optical histological prediction (Hyperplastic vs Adenoma). | Supports the “Resect and Discard” paradigm, drastically cutting pathology costs. |
The Silicon Second Observer
Artificial Intelligence in endoscopy is no longer a beta-stage novelty; in 2026, it is a commercial reality integrated directly into the video processors of premium endoscopic towers (e.g., Olympus EndoBrain, Medtronic GI Genius). Specifically focused on colonoscopy, these deep-learning Convolutional Neural Networks continuously ingest the 60 frame-per-second video feed, instantly overlaying a glowing green bounding box around any subtle mucosal texture that statistically mimics a precancerous adenoma.
Streamlining the Resect and Discard Workflow
While CADe merely targets the lesion, advanced CADx algorithms actually optically predict the histology of the polyp in real time. If the AI confidently asserts the 4mm rectal polyp is a benign hyperplastic lesion, the physician can execute a cold-forceps avulsion and legally discard the tissue into the suction trap rather than sending it to an expensive third-party pathology lab. Furthermore, modern EMR software automatically bridges with the AI processor, silently pre-populating the procedural report with the exact GPS coordinates and sizes of every found lesion, entirely eliminating the data-entry burden on the endoscopist.
Clinical guidelines summarized by the Gastroscholar Research Team. Last updated: 2026. This article is intended for physicians.
